Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

INVESTOR ALERT: Goldberg Law PC Announces Securities Class Action Lawsuit Against Insulet Corporation And Advises Shareholders With Losses Exceeding $100,000 To Contact Goldberg Law PC Prior To The Lead Plaintiff Deadline

PODD

Goldberg Law PC announces that a class action lawsuit has been filed in the United States District Court, District of Massachusetts, against Insulet Corporation (NASDAQ: PODD) (“Insulet” or the “Company”), for alleged violations of the federal securities laws. Investors who purchased or otherwise acquired shares between February 27, 2013 and April 30, 2015, inclusive (the “Class Period”), have until July 6, 2015 to serve as lead plaintiff in the class action.

If you are a shareholder who suffered a loss during the Class Period, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 1404, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at info@goldberglawpc.com.

The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

Insulet is a medical device corporation that manufactures the OmniPod Insulin Management System, an insulin system for patients with insulin-dependent diabetes. The complaint alleges that during the class period Insulet made false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing weaker demand for its products; (2) the Company was having problems related to its sales and marketing efforts; (3) as a result, the Company experienced unevenness in its financial performance; and (4) as a result of the foregoing, Insulets’ positive statements about the Company’s business, prospects, and operations lacked a reasonable basis. On May 1, 2015, shares fell almost 10% as a result of Insulet’s disappointing first quarter results.

If you have any questions concerning your legal rights in this case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at info@goldberglawpc.com.

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq. 800-977-7401
or
Brian Schall, Esq. 800-977-7401
info@goldberglawpc.com
Goldberglawpc.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today